isoniazid has been researched along with 19-hydroxy-5,8,11,14-eicosatetraenoic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frye, RF; Poloyac, SM; Przychodzin, DI; Reynolds, RB; Tortorici, MA; Xie, W; Zemaitis, MA | 1 |
Abdelhamid, G; El-Kadi, AO; El-Sherbeni, AA; Elkhatali, S; Elshenawy, OH | 1 |
2 other study(ies) available for isoniazid and 19-hydroxy-5,8,11,14-eicosatetraenoic acid
Article | Year |
---|---|
The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney.
Topics: Animals; Arachidonic Acid; Blotting, Western; Chlorzoxazone; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Cytochrome P-450 CYP4A; Dichloroethylenes; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hydroxylation; Isoniazid; Kidney; Lauric Acids; Liver; Male; Mixed Function Oxygenases; Rats; Rats, Sprague-Dawley | 2004 |
19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Arachidonic Acid; Cardiomegaly; Cells, Cultured; Cytochrome P-450 Enzyme System; Humans; Hydroxyeicosatetraenoic Acids; Isoniazid; Male; Myocytes, Cardiac; Protective Agents; Rats; Rats, Sprague-Dawley | 2015 |